MELANIE SUAREZ-MURIAS: Open Payments
NPI 1649678905 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$386 in 12 payments from 7 companies in 2025. Trend: 2023 $361 · 2024 $404 · 2025 $386
Food & beverage: $386
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $119 |
| Merck Sharp & Dohme LLC | 4 | $97 |
| JAZZ PHARMACEUTICALS INC. | 2 | $47 |
| Janssen Biotech, Inc. | 2 | $46 |
| ARRAY BIOPHARMA INC | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| PFIZER INC. | 1 | $23 |
Products named: ALUNBRIG, KEYTRUDA, ZEPZELCA, XALKORI, DARZALEX, TAGRISSO, ELIQUIS, RYBREVANT.
Industry payments across FL — which companies pay providers there.
